Reviewed By:
Benjamin Kummer, MD (Neurology)
Dr Kummer is Assistant Professor of Neurology at the Icahn School of Medicine at Mount Sinai (ISMMS), with joint appointment in Digital and Technology Partners (DTP) at the Mount Sinai Health System (MSHS) as Director of Clinical Informatics in Neurology. As a triple-board certified practicing stroke neurologist and informaticist, he has successfully improved clinical operations at the point of care by acting as a central liaison between clinical neurology faculty and DTP teams to implement targeted EHR configuration changes and workflows, as well as providing subject matter expertise on health information technology projects across MSHS. | Dr Kummer also has several years’ experience building and implementing several informatics tools, presenting scientific posters, and generating a body of peer-reviewed work in “clinical neuro-informatics” – i.e., the intersection of clinical neurology, digital health, and informatics – much of which is centered on digital/tele-health, artificial intelligence, and machine learning. He has spearheaded the Clinical Neuro-Informatics Center in the Department of Neurology at ISMMS, a new research institute that seeks to establish the field of clinical neuro-informatics and disseminate knowledge to the neurological community on the effects and benefits of clinical informatics tools at the point of care.
Shohei Harase, MD (Neurology)
Dr. Harase spent his junior and senior high school years in Finland and the U.S. After graduating from the University of Washington (Bachelor of Science, Molecular and Cellular Biology), he worked for Apple Japan Inc. before entering the University of the Ryukyus School of Medicine. He completed his residency at Okinawa Prefectural Chubu Hospital, where he received the Best Resident Award in 2016 and 2017. In 2021, he joined the Department of Cerebrovascular Medicine at the National Cerebral and Cardiovascular Center, specializing in hyperacute stroke.
Content updated on Nov 15, 2024
Following the Medical Content Editorial Policy
Worried about your symptoms?
Start the Multiple Sclerosis (MS) test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Facial tingling
Pins and needles
Double vision
Blurred vision
Numbness and tingling
Muscle weakness
Tingling in feet
Tingling in arm
Coordination problems
Vision problems
Pins and needles in feet
Can't focus
Not seeing your symptoms? No worries!
With a free 3-min Multiple Sclerosis (MS) quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Female, 30s
I was having pain in the back of my eyes and constant dizziness. At first, I thought it was because of my stress, and I google my symptoms. I found the information on Google intimidating and felt like I’m dying. I used Ubie to check my symptoms, and it told me that I have MS and recommended to see a doctor. I was surprised when I took the blood test, the result was the same as what Ubie said
(Nov 15, 2022)
Female, 50s
I had contact pain in my back which worsened in the last year. One of my friends recommended Ubie for me to try, and I liked the experience of it! I felt like Ubie asked me proper questions, and the result was very informative. Ubie says I have MS, so I showed the screen to the doctor, confirmed the accuracy, and received the same advice!
(Oct 20, 2022)
Female, 30s
I was convinced I had MS from everything I've been reading online. However, my result was not marked as MS at all. This quiz brought my wild imagination and me back down to earth and helped calm me down.
(Mar 30, 2024)
Multiple sclerosis (MS) disease in which the immune system attacks parts of the brain and spinal cord. The direct cause of MS remains unknown, but certain risk factors have been identified such as low vitamin D levels, tobacco smoking, exposure to UV radiation, childhood obesity, and infection with the virus that causes mononucleosis. The disease tends to affect young people more commonly as well as people living in higher latitudes. MS typically occurs in "attacks" which can include but are not limited to painful eye movements, blurry vision in one eye, numbness or weakness in hands or feet on one side, or double vision.
Your doctor may ask these questions to check for this disease:
Treatment of MS includes medications, physical/occupational therapy, lifestyle changes, and psychological support. Some medications prevent immune system attacks on the central nervous system, whereas others speed up recovery from attacks, or others reduce MS symptoms such as urinary problems or imbalanced walking. Physical therapy accelerates recovery from attacks and Lifestyle changes like quitting smoking can help reduce risk of further attacks.
Q.
What Is the Life Expectancy of Multiple Sclerosis?
A.
While life expectancy has been increasing for people with multiple sclerosis (MS), recent evidence suggests life expectancy is lower (about 7 years) than the general population. However, there is considerable variation in disease progression on an individual basis.
References:
Lunde HMB, Assmus J, Myhr KM, BL, Grytten N. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):621-625. doi: 10.1136/jnnp-2016-315238. Epub 2017 Apr 1. PMID: 28365589; PMCID: PMC5537547.
McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA. 2021;325(8):765–779. doi:10.1001/jama.2020.26858
https://jamanetwork.com/journals/jama/article-abstract/2776694?casa_token=7gSU0m74lwoAAAAA:i0Mg1HziIGHT23muifKVtyc23MYu5YHqSm0tvuWhos5tIhfhHKyoavVwFAJsHfds_MCG4Kswo0eZDobson R, Giovannoni G. Multiple sclerosis–a review. European journal of neurology. 2019 Jan;26(1):27-40.
https://onlinelibrary.wiley.com/doi/10.1111/ene.13819Hauser SL, Cree BA. Treatment of multiple sclerosis: a review. The American journal of medicine. 2020 Dec 1;133(12):1380-90.
Reviewed By:
Benjamin Kummer, MD (Neurology)
Dr Kummer is Assistant Professor of Neurology at the Icahn School of Medicine at Mount Sinai (ISMMS), with joint appointment in Digital and Technology Partners (DTP) at the Mount Sinai Health System (MSHS) as Director of Clinical Informatics in Neurology. As a triple-board certified practicing stroke neurologist and informaticist, he has successfully improved clinical operations at the point of care by acting as a central liaison between clinical neurology faculty and DTP teams to implement targeted EHR configuration changes and workflows, as well as providing subject matter expertise on health information technology projects across MSHS. | Dr Kummer also has several years’ experience building and implementing several informatics tools, presenting scientific posters, and generating a body of peer-reviewed work in “clinical neuro-informatics” – i.e., the intersection of clinical neurology, digital health, and informatics – much of which is centered on digital/tele-health, artificial intelligence, and machine learning. He has spearheaded the Clinical Neuro-Informatics Center in the Department of Neurology at ISMMS, a new research institute that seeks to establish the field of clinical neuro-informatics and disseminate knowledge to the neurological community on the effects and benefits of clinical informatics tools at the point of care.
Shohei Harase, MD (Neurology)
Dr. Harase spent his junior and senior high school years in Finland and the U.S. After graduating from the University of Washington (Bachelor of Science, Molecular and Cellular Biology), he worked for Apple Japan Inc. before entering the University of the Ryukyus School of Medicine. He completed his residency at Okinawa Prefectural Chubu Hospital, where he received the Best Resident Award in 2016 and 2017. In 2021, he joined the Department of Cerebrovascular Medicine at the National Cerebral and Cardiovascular Center, specializing in hyperacute stroke.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1